Intralipid Use at Reperfusion: Impact on Myocardial IRI in CABG



Coronary heart disease remains the leading global cause of death. Despite advancements in managing ischemic heart disease, outcomes are still poor due to myocardial ischemia-reperfusion (IRI) injury. Identifying new therapies to limit IRI is crucial for improving patient mortality and morbidity.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our